Duloxetine for the long-term treatment of major depressive disorder in patients aged 65 and older: an open-label study
about
Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability.Continuation treatment of major depressive disorder: is there a case for duloxetine?Duloxetine and care management treatment of older adults with comorbid major depressive disorder and chronic low back pain: results of an open-label pilot studyDuloxetine in practice-based clinical settings: assessing effects on the emotional and physical symptoms of depression in an open-label, multicenter study.Duloxetine in the treatment of major psychiatric and neuropathic disorders.Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials.Safety and adverse event profile of duloxetine.Duloxetine: a new selective and dual-acting antidepressant.Adverse reactions to duloxetine in depression.A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.Duloxetine: a review of its use in the management of major depressive disorder in older adults.Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels.Vascular depression: overrepresented among African Americans?Duloxetine in elderly major depression disorder: effectiveness and drug plasma level evaluation.
P2860
Q33755508-0AD30967-E1AB-4956-B94C-E00C9DA5A76FQ33755767-20256045-983B-4921-B095-AFE91E9C7A62Q33857444-41FC11E0-6400-4804-9394-B500FAE50408Q34700765-929AA53C-FE67-416B-8C6A-8EE0D0CD2427Q34770302-E365D46E-15E3-4950-A6AB-D6661BCDC0C7Q36270312-FC9BC58D-3E73-4333-BDB2-9DFEF13B9178Q36299961-2B1B730D-37D5-42CD-8C5B-BB6D0F76B1A4Q36407366-A8CA2904-D947-4B98-9C4D-0FDA6E438670Q37872294-58F26B71-F75F-467D-A2FE-A914B309A34AQ38020236-38B53664-DFF7-410B-8757-E391739E1ABBQ38067355-0E138911-2D95-4ABA-B49B-DF73B366C0C8Q42619331-47784E5D-34C5-4429-8242-046AC06071E5Q42623204-71C8CD72-CCB6-4D52-8367-2D7623FCB168Q47984936-90BD9950-D546-431E-AF10-FC8393A7B10B
P2860
Duloxetine for the long-term treatment of major depressive disorder in patients aged 65 and older: an open-label study
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Duloxetine for the long-term t ...... and older: an open-label study
@ast
Duloxetine for the long-term t ...... and older: an open-label study
@en
Duloxetine for the long-term t ...... and older: an open-label study
@nl
type
label
Duloxetine for the long-term t ...... and older: an open-label study
@ast
Duloxetine for the long-term t ...... and older: an open-label study
@en
Duloxetine for the long-term t ...... and older: an open-label study
@nl
prefLabel
Duloxetine for the long-term t ...... and older: an open-label study
@ast
Duloxetine for the long-term t ...... and older: an open-label study
@en
Duloxetine for the long-term t ...... and older: an open-label study
@nl
P2093
P2860
P356
P1433
P1476
Duloxetine for the long-term t ...... and older: an open-label study
@en
P2093
Craig H Mallinckrodt
Donald P Hay
John G Watkin
Madelaine M Wohlreich
P2860
P2888
P356
10.1186/1471-2318-4-11
P407
P577
2004-12-07T00:00:00Z
P5875
P6179
1034393252